Systemic and Intraocular Methotrexate for the Prevention and Treatment of Proliferative Vitreoretinopathy in Children With Rhegmatogenous Retinal Detachment and Underlying Inflammatory Disease.
Journal of vitreoretinal diseases(2022)
摘要
The safety and efficacy of this combination therapy suggests that it could be a successful strategy for treating pediatric patients with RRD with or without PVR in the presence or absence of underlying inflammatory diseases.
更多查看译文
关键词
immunosuppression,inflammation,methotrexate,pediatric rhegmatogenous retinal detachment (RRD),proliferative vitreoretinopathy (PVR)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要